Click for best price
Liposomal Drug Delivery Device Market Size, Share 2023
This report contains market size and forecasts of Liposomal Drug Delivery Device in Global, including the following market information:
Global Liposomal Drug Delivery Device Market Revenue, 2018-2023, 2023-2030, ($ millions)
Global top five companies in 2022 (%)
The global Liposomal Drug Delivery Device market was valued at US$ million in 2022 and is projected to reach US$ million by 2030, at a CAGR of % during the forecast period 2023-2030.
The U.S. Market is Estimated at $ Million in 2022, While China is Forecast to Reach $ Million by 2030.
Stealth Liposome Technology Segment to Reach $ Million by 2030, with a % CAGR in next six years.
The global key manufacturers of Liposomal Drug Delivery Device include Novartis AG, Luye Pharma Group, Ipsen Pharma, Celsion, Inc., Galen Limited, Astellas Pharma, Inc., Acrotech Biopharma, Inc., Fudan-Zhangjiang and Pacira, etc. In 2022, the global top five players have a share approximately % in terms of revenue.
We has surveyed the Liposomal Drug Delivery Device companies, and industry experts on this industry, involving the revenue, demand, product type, recent developments and plans, industry trends, drivers, challenges, obstacles, and potential risks.
Total Market by Segment:
Global Liposomal Drug Delivery Device Market, by Type, 2018-2023, 2023-2030 ($ millions)
Global Liposomal Drug Delivery Device Market Segment Percentages, by Type, 2022 (%)
Stealth Liposome Technology
NonPEGylated Liposome Technology
DepoFoam Liposome Technology
Global Liposomal Drug Delivery Device Market, by Application, 2018-2023, 2023-2030 ($ millions)
Global Liposomal Drug Delivery Device Market Segment Percentages, by Application, 2022 (%)
Fungal Diseases
Cancer Therapy
Pain Management
Viral Vaccines
Photodynamic Therapy
Global Liposomal Drug Delivery Device Market, By Region and Country, 2018-2023, 2023-2030 ($ Millions)
Global Liposomal Drug Delivery Device Market Segment Percentages, By Region and Country, 2022 (%)
North America
US
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Nordic Countries
Benelux
Rest of Europe
Asia
China
Japan
South Korea
Southeast Asia
India
Rest of Asia
South America
Brazil
Argentina
Rest of South America
Middle East & Africa
Turkey
Israel
Saudi Arabia
UAE
Rest of Middle East & Africa
Competitor Analysis
The report also provides analysis of leading market participants including:
Key companies Liposomal Drug Delivery Device revenues in global market, 2018-2023 (estimated), ($ millions)
Key companies Liposomal Drug Delivery Device revenues share in global market, 2022 (%)
Further, the report presents profiles of competitors in the market, key players include:
Novartis AG
Luye Pharma Group
Ipsen Pharma
Celsion, Inc.
Galen Limited
Astellas Pharma, Inc.
Acrotech Biopharma, Inc.
Fudan-Zhangjiang
Pacira
Creative Biolabs
Precision NanoSystems Inc.
Encapsula NanoSciences LLC
Avanti Polar Lipids, Inc.
Viatris Inc.
Merrimack Pharmaceuticals, Inc
| Report Attributes |
Report Details |
| Report Title |
Liposomal Drug Delivery Device Market, Global Outlook and Forecast 2023-2030 |
| Historical Year |
2018 to 2022 (Data from 2010 can be provided as per availability) |
| Base Year |
2022 |
| Forecast Year |
2030 |
| Number of Pages |
105 Pages |
| Customization Available |
Yes, the report can be customized as per your need. |
TABLE OF CONTENTS
1 Introduction to Research & Analysis Reports
1.1 Liposomal Drug Delivery Device Market Definition
1.2 Market Segments
1.2.1 Market by Type
1.2.2 Market by Application
1.3 Global Liposomal Drug Delivery Device Market Overview
1.4 Features & Benefits of This Report
1.5 Methodology & Sources of Information
1.5.1 Research Methodology
1.5.2 Research Process
1.5.3 Base Year
1.5.4 Report Assumptions & Caveats
2 Global Liposomal Drug Delivery Device Overall Market Size
2.1 Global Liposomal Drug Delivery Device Market Size: 2022 VS 2030
2.2 Global Liposomal Drug Delivery Device Market Size, Prospects & Forecasts: 2018-2030
2.3 Key Market Trends, Opportunity, Drivers and Restraints
2.3.1 Market Opportunities & Trends
2.3.2 Market Drivers
2.3.3 Market Restraints
3 Company Landscape
3.1 Top Liposomal Drug Delivery Device Players in Global Market
3.2 Top Global Liposomal Drug Delivery Device Companies Ranked by Revenue
3.3 Global Liposomal Drug Delivery Device Revenue by Companies
3.4 Top 3 and Top 5 Liposomal Drug Delivery Device Companies in Global Market, by Revenue in 2022
3.5 Global Companies Liposomal Drug Delivery Device Product Type
3.6 Tier 1, Tier 2 and Tier 3 Liposomal Drug Delivery Device Players in Global Market
3.6.1 List of Global Tier 1 Liposomal Drug Delivery Device Companies
3.6.2 List of Global Tier 2 and Tier 3 Liposomal Drug Delivery Device Companies
4 Market Sights by Product
4.1 Overview
4.1.1 by Type - Global Liposomal Drug Delivery Device Market Size Markets, 2022 & 2030
4.1.2 Stealth Liposome Technology
4.1.3 NonPEGylated Liposome Technology
4.1.4 DepoFoam Liposome Technology
4.2 By Type - Global Liposomal Drug Delivery Device Revenue & Forecasts
4.2.1 By Type - Global Liposomal Drug Delivery Device Revenue, 2018-2023
4.2.2 By Type - Global Liposomal Drug Delivery Device Revenue, 2023-2030
4.2.3 By Type - Global Liposomal Drug Delivery Device Revenue Market Share, 2018-2030
5 Sights by Application
5.1 Overview
5.1.1 By Application - Global Liposomal Drug Delivery Device Market Size, 2022 & 2030
5.1.2 Fungal Diseases
5.1.3 Cancer Therapy
5.1.4 Pain Management
5.1.5 Viral Vaccines
5.1.6 Photodynamic Therapy
5.2 By Application - Global Liposomal Drug Delivery Device Revenue & Forecasts
5.2.1 By Application - Global Liposomal Drug Delivery Device Revenue, 2018-2023
5.2.2 By Application - Global Liposomal Drug Delivery Device Revenue, 2023-2030
5.2.3 By Application - Global Liposomal Drug Delivery Device Revenue Market Share, 2018-2030
6 Sights by Region
6.1 By Region - Global Liposomal Drug Delivery Device Market Size, 2022 & 2030
6.2 By Region - Global Liposomal Drug Delivery Device Revenue & Forecasts
6.2.1 By Region - Global Liposomal Drug Delivery Device Revenue, 2018-2023
6.2.2 By Region - Global Liposomal Drug Delivery Device Revenue, 2023-2030
6.2.3 By Region - Global Liposomal Drug Delivery Device Revenue Market Share, 2018-2030
6.3 North America
6.3.1 By Country - North America Liposomal Drug Delivery Device Revenue, 2018-2030
6.3.2 US Liposomal Drug Delivery Device Market Size, 2018-2030
6.3.3 Canada Liposomal Drug Delivery Device Market Size, 2018-2030
6.3.4 Mexico Liposomal Drug Delivery Device Market Size, 2018-2030
6.4 Europe
6.4.1 By Country - Europe Liposomal Drug Delivery Device Revenue, 2018-2030
6.4.2 Germany Liposomal Drug Delivery Device Market Size, 2018-2030
6.4.3 France Liposomal Drug Delivery Device Market Size, 2018-2030
6.4.4 U.K. Liposomal Drug Delivery Device Market Size, 2018-2030
6.4.5 Italy Liposomal Drug Delivery Device Market Size, 2018-2030
6.4.6 Russia Liposomal Drug Delivery Device Market Size, 2018-2030
6.4.7 Nordic Countries Liposomal Drug Delivery Device Market Size, 2018-2030
6.4.8 Benelux Liposomal Drug Delivery Device Market Size, 2018-2030
6.5 Asia
6.5.1 By Region - Asia Liposomal Drug Delivery Device Revenue, 2018-2030
6.5.2 China Liposomal Drug Delivery Device Market Size, 2018-2030
6.5.3 Japan Liposomal Drug Delivery Device Market Size, 2018-2030
6.5.4 South Korea Liposomal Drug Delivery Device Market Size, 2018-2030
6.5.5 Southeast Asia Liposomal Drug Delivery Device Market Size, 2018-2030
6.5.6 India Liposomal Drug Delivery Device Market Size, 2018-2030
6.6 South America
6.6.1 By Country - South America Liposomal Drug Delivery Device Revenue, 2018-2030
6.6.2 Brazil Liposomal Drug Delivery Device Market Size, 2018-2030
6.6.3 Argentina Liposomal Drug Delivery Device Market Size, 2018-2030
6.7 Middle East & Africa
6.7.1 By Country - Middle East & Africa Liposomal Drug Delivery Device Revenue, 2018-2030
6.7.2 Turkey Liposomal Drug Delivery Device Market Size, 2018-2030
6.7.3 Israel Liposomal Drug Delivery Device Market Size, 2018-2030
6.7.4 Saudi Arabia Liposomal Drug Delivery Device Market Size, 2018-2030
6.7.5 UAE Liposomal Drug Delivery Device Market Size, 2018-2030
7 Players Profiles
7.1 Novartis AG
7.1.1 Novartis AG Corporate Summary
7.1.2 Novartis AG Business Overview
7.1.3 Novartis AG Liposomal Drug Delivery Device Major Product Offerings
7.1.4 Novartis AG Liposomal Drug Delivery Device Revenue in Global Market (2018-2023)
7.1.5 Novartis AG Key News
7.2 Luye Pharma Group
7.2.1 Luye Pharma Group Corporate Summary
7.2.2 Luye Pharma Group Business Overview
7.2.3 Luye Pharma Group Liposomal Drug Delivery Device Major Product Offerings
7.2.4 Luye Pharma Group Liposomal Drug Delivery Device Revenue in Global Market (2018-2023)
7.2.5 Luye Pharma Group Key News
7.3 Ipsen Pharma
7.3.1 Ipsen Pharma Corporate Summary
7.3.2 Ipsen Pharma Business Overview
7.3.3 Ipsen Pharma Liposomal Drug Delivery Device Major Product Offerings
7.3.4 Ipsen Pharma Liposomal Drug Delivery Device Revenue in Global Market (2018-2023)
7.3.5 Ipsen Pharma Key News
7.4 Celsion, Inc.
7.4.1 Celsion, Inc. Corporate Summary
7.4.2 Celsion, Inc. Business Overview
7.4.3 Celsion, Inc. Liposomal Drug Delivery Device Major Product Offerings
7.4.4 Celsion, Inc. Liposomal Drug Delivery Device Revenue in Global Market (2018-2023)
7.4.5 Celsion, Inc. Key News
7.5 Galen Limited
7.5.1 Galen Limited Corporate Summary
7.5.2 Galen Limited Business Overview
7.5.3 Galen Limited Liposomal Drug Delivery Device Major Product Offerings
7.5.4 Galen Limited Liposomal Drug Delivery Device Revenue in Global Market (2018-2023)
7.5.5 Galen Limited Key News
7.6 Astellas Pharma, Inc.
7.6.1 Astellas Pharma, Inc. Corporate Summary
7.6.2 Astellas Pharma, Inc. Business Overview
7.6.3 Astellas Pharma, Inc. Liposomal Drug Delivery Device Major Product Offerings
7.6.4 Astellas Pharma, Inc. Liposomal Drug Delivery Device Revenue in Global Market (2018-2023)
7.6.5 Astellas Pharma, Inc. Key News
7.7 Acrotech Biopharma, Inc.
7.7.1 Acrotech Biopharma, Inc. Corporate Summary
7.7.2 Acrotech Biopharma, Inc. Business Overview
7.7.3 Acrotech Biopharma, Inc. Liposomal Drug Delivery Device Major Product Offerings
7.7.4 Acrotech Biopharma, Inc. Liposomal Drug Delivery Device Revenue in Global Market (2018-2023)
7.7.5 Acrotech Biopharma, Inc. Key News
7.8 Fudan-Zhangjiang
7.8.1 Fudan-Zhangjiang Corporate Summary
7.8.2 Fudan-Zhangjiang Business Overview
7.8.3 Fudan-Zhangjiang Liposomal Drug Delivery Device Major Product Offerings
7.8.4 Fudan-Zhangjiang Liposomal Drug Delivery Device Revenue in Global Market (2018-2023)
7.8.5 Fudan-Zhangjiang Key News
7.9 Pacira
7.9.1 Pacira Corporate Summary
7.9.2 Pacira Business Overview
7.9.3 Pacira Liposomal Drug Delivery Device Major Product Offerings
7.9.4 Pacira Liposomal Drug Delivery Device Revenue in Global Market (2018-2023)
7.9.5 Pacira Key News
7.10 Creative Biolabs
7.10.1 Creative Biolabs Corporate Summary
7.10.2 Creative Biolabs Business Overview
7.10.3 Creative Biolabs Liposomal Drug Delivery Device Major Product Offerings
7.10.4 Creative Biolabs Liposomal Drug Delivery Device Revenue in Global Market (2018-2023)
7.10.5 Creative Biolabs Key News
7.11 Precision NanoSystems Inc.
7.11.1 Precision NanoSystems Inc. Corporate Summary
7.11.2 Precision NanoSystems Inc. Business Overview
7.11.3 Precision NanoSystems Inc. Liposomal Drug Delivery Device Major Product Offerings
7.11.4 Precision NanoSystems Inc. Liposomal Drug Delivery Device Revenue in Global Market (2018-2023)
7.11.5 Precision NanoSystems Inc. Key News
7.12 Encapsula NanoSciences LLC
7.12.1 Encapsula NanoSciences LLC Corporate Summary
7.12.2 Encapsula NanoSciences LLC Business Overview
7.12.3 Encapsula NanoSciences LLC Liposomal Drug Delivery Device Major Product Offerings
7.12.4 Encapsula NanoSciences LLC Liposomal Drug Delivery Device Revenue in Global Market (2018-2023)
7.12.5 Encapsula NanoSciences LLC Key News
7.13 Avanti Polar Lipids, Inc.
7.13.1 Avanti Polar Lipids, Inc. Corporate Summary
7.13.2 Avanti Polar Lipids, Inc. Business Overview
7.13.3 Avanti Polar Lipids, Inc. Liposomal Drug Delivery Device Major Product Offerings
7.13.4 Avanti Polar Lipids, Inc. Liposomal Drug Delivery Device Revenue in Global Market (2018-2023)
7.13.5 Avanti Polar Lipids, Inc. Key News
7.14 Viatris Inc.
7.14.1 Viatris Inc. Corporate Summary
7.14.2 Viatris Inc. Business Overview
7.14.3 Viatris Inc. Liposomal Drug Delivery Device Major Product Offerings
7.14.4 Viatris Inc. Liposomal Drug Delivery Device Revenue in Global Market (2018-2023)
7.14.5 Viatris Inc. Key News
7.15 Merrimack Pharmaceuticals, Inc
7.15.1 Merrimack Pharmaceuticals, Inc Corporate Summary
7.15.2 Merrimack Pharmaceuticals, Inc Business Overview
7.15.3 Merrimack Pharmaceuticals, Inc Liposomal Drug Delivery Device Major Product Offerings
7.15.4 Merrimack Pharmaceuticals, Inc Liposomal Drug Delivery Device Revenue in Global Market (2018-2023)
7.15.5 Merrimack Pharmaceuticals, Inc Key News
8 Conclusion
9 Appendix
9.1 Note
9.2 Examples of Clients
9.3 Disclaimer
LIST OF TABLES & FIGURES
List of Tables
Table 1. Liposomal Drug Delivery Device Market Opportunities & Trends in Global Market
Table 2. Liposomal Drug Delivery Device Market Drivers in Global Market
Table 3. Liposomal Drug Delivery Device Market Restraints in Global Market
Table 4. Key Players of Liposomal Drug Delivery Device in Global Market
Table 5. Top Liposomal Drug Delivery Device Players in Global Market, Ranking by Revenue (2022)
Table 6. Global Liposomal Drug Delivery Device Revenue by Companies, (US$, Mn), 2018-2023
Table 7. Global Liposomal Drug Delivery Device Revenue Share by Companies, 2018-2023
Table 8. Global Companies Liposomal Drug Delivery Device Product Type
Table 9. List of Global Tier 1 Liposomal Drug Delivery Device Companies, Revenue (US$, Mn) in 2022 and Market Share
Table 10. List of Global Tier 2 and Tier 3 Liposomal Drug Delivery Device Companies, Revenue (US$, Mn) in 2022 and Market Share
Table 11. By Type ? Global Liposomal Drug Delivery Device Revenue, (US$, Mn), 2022 & 2030
Table 12. By Type - Liposomal Drug Delivery Device Revenue in Global (US$, Mn), 2018-2023
Table 13. By Type - Liposomal Drug Delivery Device Revenue in Global (US$, Mn), 2023-2030
Table 14. By Application ? Global Liposomal Drug Delivery Device Revenue, (US$, Mn), 2022 & 2030
Table 15. By Application - Liposomal Drug Delivery Device Revenue in Global (US$, Mn), 2018-2023
Table 16. By Application - Liposomal Drug Delivery Device Revenue in Global (US$, Mn), 2023-2030
Table 17. By Region ? Global Liposomal Drug Delivery Device Revenue, (US$, Mn), 2022 & 2030
Table 18. By Region - Global Liposomal Drug Delivery Device Revenue (US$, Mn), 2018-2023
Table 19. By Region - Global Liposomal Drug Delivery Device Revenue (US$, Mn), 2023-2030
Table 20. By Country - North America Liposomal Drug Delivery Device Revenue, (US$, Mn), 2018-2023
Table 21. By Country - North America Liposomal Drug Delivery Device Revenue, (US$, Mn), 2023-2030
Table 22. By Country - Europe Liposomal Drug Delivery Device Revenue, (US$, Mn), 2018-2023
Table 23. By Country - Europe Liposomal Drug Delivery Device Revenue, (US$, Mn), 2023-2030
Table 24. By Region - Asia Liposomal Drug Delivery Device Revenue, (US$, Mn), 2018-2023
Table 25. By Region - Asia Liposomal Drug Delivery Device Revenue, (US$, Mn), 2023-2030
Table 26. By Country - South America Liposomal Drug Delivery Device Revenue, (US$, Mn), 2018-2023
Table 27. By Country - South America Liposomal Drug Delivery Device Revenue, (US$, Mn), 2023-2030
Table 28. By Country - Middle East & Africa Liposomal Drug Delivery Device Revenue, (US$, Mn), 2018-2023
Table 29. By Country - Middle East & Africa Liposomal Drug Delivery Device Revenue, (US$, Mn), 2023-2030
Table 30. Novartis AG Corporate Summary
Table 31. Novartis AG Liposomal Drug Delivery Device Product Offerings
Table 32. Novartis AG Liposomal Drug Delivery Device Revenue (US$, Mn), (2018-2023)
Table 33. Luye Pharma Group Corporate Summary
Table 34. Luye Pharma Group Liposomal Drug Delivery Device Product Offerings
Table 35. Luye Pharma Group Liposomal Drug Delivery Device Revenue (US$, Mn), (2018-2023)
Table 36. Ipsen Pharma Corporate Summary
Table 37. Ipsen Pharma Liposomal Drug Delivery Device Product Offerings
Table 38. Ipsen Pharma Liposomal Drug Delivery Device Revenue (US$, Mn), (2018-2023)
Table 39. Celsion, Inc. Corporate Summary
Table 40. Celsion, Inc. Liposomal Drug Delivery Device Product Offerings
Table 41. Celsion, Inc. Liposomal Drug Delivery Device Revenue (US$, Mn), (2018-2023)
Table 42. Galen Limited Corporate Summary
Table 43. Galen Limited Liposomal Drug Delivery Device Product Offerings
Table 44. Galen Limited Liposomal Drug Delivery Device Revenue (US$, Mn), (2018-2023)
Table 45. Astellas Pharma, Inc. Corporate Summary
Table 46. Astellas Pharma, Inc. Liposomal Drug Delivery Device Product Offerings
Table 47. Astellas Pharma, Inc. Liposomal Drug Delivery Device Revenue (US$, Mn), (2018-2023)
Table 48. Acrotech Biopharma, Inc. Corporate Summary
Table 49. Acrotech Biopharma, Inc. Liposomal Drug Delivery Device Product Offerings
Table 50. Acrotech Biopharma, Inc. Liposomal Drug Delivery Device Revenue (US$, Mn), (2018-2023)
Table 51. Fudan-Zhangjiang Corporate Summary
Table 52. Fudan-Zhangjiang Liposomal Drug Delivery Device Product Offerings
Table 53. Fudan-Zhangjiang Liposomal Drug Delivery Device Revenue (US$, Mn), (2018-2023)
Table 54. Pacira Corporate Summary
Table 55. Pacira Liposomal Drug Delivery Device Product Offerings
Table 56. Pacira Liposomal Drug Delivery Device Revenue (US$, Mn), (2018-2023)
Table 57. Creative Biolabs Corporate Summary
Table 58. Creative Biolabs Liposomal Drug Delivery Device Product Offerings
Table 59. Creative Biolabs Liposomal Drug Delivery Device Revenue (US$, Mn), (2018-2023)
Table 60. Precision NanoSystems Inc. Corporate Summary
Table 61. Precision NanoSystems Inc. Liposomal Drug Delivery Device Product Offerings
Table 62. Precision NanoSystems Inc. Liposomal Drug Delivery Device Revenue (US$, Mn), (2018-2023)
Table 63. Encapsula NanoSciences LLC Corporate Summary
Table 64. Encapsula NanoSciences LLC Liposomal Drug Delivery Device Product Offerings
Table 65. Encapsula NanoSciences LLC Liposomal Drug Delivery Device Revenue (US$, Mn), (2018-2023)
Table 66. Avanti Polar Lipids, Inc. Corporate Summary
Table 67. Avanti Polar Lipids, Inc. Liposomal Drug Delivery Device Product Offerings
Table 68. Avanti Polar Lipids, Inc. Liposomal Drug Delivery Device Revenue (US$, Mn), (2018-2023)
Table 69. Viatris Inc. Corporate Summary
Table 70. Viatris Inc. Liposomal Drug Delivery Device Product Offerings
Table 71. Viatris Inc. Liposomal Drug Delivery Device Revenue (US$, Mn), (2018-2023)
Table 72. Merrimack Pharmaceuticals, Inc Corporate Summary
Table 73. Merrimack Pharmaceuticals, Inc Liposomal Drug Delivery Device Product Offerings
Table 74. Merrimack Pharmaceuticals, Inc Liposomal Drug Delivery Device Revenue (US$, Mn), (2018-2023)
List of Figures
Figure 1. Liposomal Drug Delivery Device Segment by Type in 2022
Figure 2. Liposomal Drug Delivery Device Segment by Application in 2022
Figure 3. Global Liposomal Drug Delivery Device Market Overview: 2022
Figure 4. Key Caveats
Figure 5. Global Liposomal Drug Delivery Device Market Size: 2022 VS 2030 (US$, Mn)
Figure 6. Global Liposomal Drug Delivery Device Revenue, 2018-2030 (US$, Mn)
Figure 7. The Top 3 and 5 Players Market Share by Liposomal Drug Delivery Device Revenue in 2022
Figure 8. By Type - Global Liposomal Drug Delivery Device Revenue Market Share, 2018-2030
Figure 9. By Application - Global Liposomal Drug Delivery Device Revenue Market Share, 2018-2030
Figure 10. By Region - Global Liposomal Drug Delivery Device Revenue Market Share, 2018-2030
Figure 11. By Country - North America Liposomal Drug Delivery Device Revenue Market Share, 2018-2030
Figure 12. US Liposomal Drug Delivery Device Revenue, (US$, Mn), 2018-2030
Figure 13. Canada Liposomal Drug Delivery Device Revenue, (US$, Mn), 2018-2030
Figure 14. Mexico Liposomal Drug Delivery Device Revenue, (US$, Mn), 2018-2030
Figure 15. By Country - Europe Liposomal Drug Delivery Device Revenue Market Share, 2018-2030
Figure 16. Germany Liposomal Drug Delivery Device Revenue, (US$, Mn), 2018-2030
Figure 17. France Liposomal Drug Delivery Device Revenue, (US$, Mn), 2018-2030
Figure 18. U.K. Liposomal Drug Delivery Device Revenue, (US$, Mn), 2018-2030
Figure 19. Italy Liposomal Drug Delivery Device Revenue, (US$, Mn), 2018-2030
Figure 20. Russia Liposomal Drug Delivery Device Revenue, (US$, Mn), 2018-2030
Figure 21. Nordic Countries Liposomal Drug Delivery Device Revenue, (US$, Mn), 2018-2030
Figure 22. Benelux Liposomal Drug Delivery Device Revenue, (US$, Mn), 2018-2030
Figure 23. By Region - Asia Liposomal Drug Delivery Device Revenue Market Share, 2018-2030
Figure 24. China Liposomal Drug Delivery Device Revenue, (US$, Mn), 2018-2030
Figure 25. Japan Liposomal Drug Delivery Device Revenue, (US$, Mn), 2018-2030
Figure 26. South Korea Liposomal Drug Delivery Device Revenue, (US$, Mn), 2018-2030
Figure 27. Southeast Asia Liposomal Drug Delivery Device Revenue, (US$, Mn), 2018-2030
Figure 28. India Liposomal Drug Delivery Device Revenue, (US$, Mn), 2018-2030
Figure 29. By Country - South America Liposomal Drug Delivery Device Revenue Market Share, 2018-2030
Figure 30. Brazil Liposomal Drug Delivery Device Revenue, (US$, Mn), 2018-2030
Figure 31. Argentina Liposomal Drug Delivery Device Revenue, (US$, Mn), 2018-2030
Figure 32. By Country - Middle East & Africa Liposomal Drug Delivery Device Revenue Market Share, 2018-2030
Figure 33. Turkey Liposomal Drug Delivery Device Revenue, (US$, Mn), 2018-2030
Figure 34. Israel Liposomal Drug Delivery Device Revenue, (US$, Mn), 2018-2030
Figure 35. Saudi Arabia Liposomal Drug Delivery Device Revenue, (US$, Mn), 2018-2030
Figure 36. UAE Liposomal Drug Delivery Device Revenue, (US$, Mn), 2018-2030
Figure 37. Novartis AG Liposomal Drug Delivery Device Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 38. Luye Pharma Group Liposomal Drug Delivery Device Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 39. Ipsen Pharma Liposomal Drug Delivery Device Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 40. Celsion, Inc. Liposomal Drug Delivery Device Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 41. Galen Limited Liposomal Drug Delivery Device Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 42. Astellas Pharma, Inc. Liposomal Drug Delivery Device Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 43. Acrotech Biopharma, Inc. Liposomal Drug Delivery Device Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 44. Fudan-Zhangjiang Liposomal Drug Delivery Device Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 45. Pacira Liposomal Drug Delivery Device Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 46. Creative Biolabs Liposomal Drug Delivery Device Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 47. Precision NanoSystems Inc. Liposomal Drug Delivery Device Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 48. Encapsula NanoSciences LLC Liposomal Drug Delivery Device Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 49. Avanti Polar Lipids, Inc. Liposomal Drug Delivery Device Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 50. Viatris Inc. Liposomal Drug Delivery Device Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 51. Merrimack Pharmaceuticals, Inc Liposomal Drug Delivery Device Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
